ClinicalTrialsFinder

Head and Neck Cancer Clinical Trials in Rozzano, Milano

2 recruitingRozzano, Milano, Italy

Showing 1–2 of 2 trials

Recruiting
Phase 2

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

Head and Neck Squamous Cell Carcinoma (HNSCC)Metastatic Head and Neck CancerRecurrent Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest67 enrolled8 locationsNCT06869473
Recruiting

The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers

Head and Neck CancerSalivary Gland CancerNasopharynx Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano13,600 enrolled12 locationsNCT05483374